| Patent | Date |
|---|
Bispecific Antibody Against Bcma And Cd3 And An Immunological Drug For Combined Use In Treating Multiple Myeloma
App 20220017631 - Vu; Minh Diem ; et al. | 2022-01-20 |
Bispecific Antibody Against Bcma And Cd3 And An Immunological Drug For Combined Use In Treating Multiple Myeloma
App 20220002427 - Vu; Minh Diem ; et al. | 2022-01-06 |
Bispecific antibody against BCMA and CD3 and an immunological drug for combined use in treating multiple myeloma
Grant 11,124,577 - Vu , et al. September 21, 2 | 2021-09-21 |
Bispecific Antibodies Against Ceacam5 And Cd47
App 20210221908 - BUATOIS; Vanessa ; et al. | 2021-07-22 |
Method For The Selection Of Antibodies Against Bcma
App 20210070873 - VU; Minh Diem ; et al. | 2021-03-11 |
Bispecific Antibodies Against Cd3epsilon And Bcma For Use In Treatment Of Diseases
App 20200385471 - Vu; Minh Diem ; et al. | 2020-12-10 |
Method for the selection of antibodies against BCMA
Grant 10,851,171 - Vu , et al. December 1, 2 | 2020-12-01 |
Monoclonal Antibodies Against Bcma
App 20200283545 - Vu; Minh Diem ; et al. | 2020-09-10 |
Bispecific Antibodies Against Cd3epsilon And Ror1
App 20200255521 - Kind Code | 2020-08-13 |
Monoclonal antibodies against BCMA
Grant 10,683,369 - Vu , et al. | 2020-06-16 |
Bispecific Antibodies Against Ceacam5 And Cd47
App 20200123252 - BUATOIS; Vanessa ; et al. | 2020-04-23 |
Monoclonal Antibodies Against Bcma
App 20190352427 - Vu; Minh Diem ; et al. | 2019-11-21 |
Bispecific Antibody Against Bcma And Cd3 And An Immunological Drug For Combined Use In Treating Multiple Myeloma
App 20190263920 - Vu; Minh Diem ; et al. | 2019-08-29 |
Bispecific antibodies against CD3 and BCMA
Grant 10,253,104 - Vu , et al. | 2019-04-09 |
Bispecific antibodies against CD3 and BCMA
Grant 10,077,315 - Vu , et al. September 18, 2 | 2018-09-18 |
Method For The Selection Of Antibodies Against Bcma
App 20180222991 - VU; Minh Diem ; et al. | 2018-08-09 |
Method for the selection of antibodies against BCMA
Grant 9,963,513 - Vu , et al. May 8, 2 | 2018-05-08 |
Bispecific Antibodies Against Cd3 Epsilon And Bcma For Use In Treatment Of Diseases
App 20170327580 - Vu; Minh Diem ; et al. | 2017-11-16 |
Bispecific Antibodies Against Cd3epsilon And Bcma
App 20170327579 - VU; MINH DIEM ; et al. | 2017-11-16 |
Bispecific Antibodies Against Cd3epsilon And Bcma
App 20170306036 - VU; Minh Diem ; et al. | 2017-10-26 |
Bispecific Antibodies Against Cd3epsilon And Ror1 For Use In The Treatment Of Ovarian Cancer
App 20170306044 - VU; MINH DIEM ; et al. | 2017-10-26 |
Bispecific Antibodies Against Cd3epsilon And Ror1
App 20170306018 - VU; MINH DIEM ; et al. | 2017-10-26 |
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1
App 20160297881 - VU; Minh Diem ; et al. | 2016-10-13 |
Bispecific Antibodies Against Cd3 And Bcma
App 20150376287 - VU; Minh Diem ; et al. | 2015-12-31 |
Method For The Selection Of Antibodies Against Bcma
App 20150368351 - VU; Minh Diem ; et al. | 2015-12-24 |
Use of carbazole compounds for the treatment of congestive heart failure
Grant RE40,707 - Lukas-Laskey , et al. May 5, 2 | 2009-05-05 |
Method of treatment for decreasing mortality resulting from congestive heart failure
Grant RE40,000 - Lukas-Laskey , et al. January 8, 2 | 2008-01-08 |
Method of treatment for decreasing mortality resulting from congestive heart failure
App 20030105138 - Lukas-Laskey, Mary Ann ; et al. | 2003-06-05 |
Method of treatment for decreasing mortality resulting from congestive heat failure
App 20010044455 - Lukas-Laskey, Mary Ann ; et al. | 2001-11-22 |
Use of carbazole compounds for the treatment of congestive heart failure
Grant 5,902,821 - Lukas-Laskey , et al. May 11, 1 | 1999-05-11 |
Method of treatment for decreasing mortality resulting from congestive heart failure
Grant 5,760,069 - Lukas-Laskey , et al. June 2, 1 | 1998-06-02 |
Pharmaceutical lactam compositions for inhibition of erythrocyte and thrombocyte aggregation
Grant 5,373,019 - Zilch , et al. December 13, 1 | 1994-12-13 |
Regimen for treatment or prophylaxis of osteoporosis
Grant 5,366,965 - Strein November 22, 1 | 1994-11-22 |
Tricyclic benzimidazole compounds, pharmaceutical compositions and methods of use
Grant 5,116,843 - Mertens , et al. May 26, 1 | 1992-05-26 |
Ureidoindoles, pharmaceutical compositions and methods for erythrocyte and thrombocyte aggregation inhibition
Grant 4,985,448 - Zilch , et al. January 15, 1 | 1991-01-15 |
Pyrrolobenzimidazoles and pharmaceutical compositions containing them
Grant 4,863,945 - Friebe , et al. September 5, 1 | 1989-09-05 |
Beta-blocking oxindole derivatives
Grant 4,826,847 - Michel , et al. May 2, 1 | 1989-05-02 |
Pyrrolobenzimidazoles, pharmaceutical compositions containing them, and use of them to treat certain heart and circulatory diseases
Grant 4,710,510 - Mertens , et al. December 1, 1 | 1987-12-01 |
Pyrrolobenzimidazoles, pharmaceutical compositions containing them and method of using them to treat certain heart and circulatory diseases
Grant 4,695,567 - Mertens , et al. September 22, 1 | 1987-09-22 |
Pharmaceutical phenylacetonitrile derivatives
Grant 4,612,313 - Leinert , et al. September 16, 1 | 1986-09-16 |
Indazoloxypropanolamine derivatives and use in combating, and for the prophylaxis of, cardiac and circulatory diseases
Grant 4,479,962 - Wiedemann , et al. October 30, 1 | 1984-10-30 |
| 